Mangalam Drugs & Organics Limited commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and Intermediates at VAPI – Gujarat in 1977. It has a multi-product manufacturing facility on two locations, and an in-house Research & Development laboratory recognized by the Department of Scientific & Industrial Research, Delhi Govt. of India (DSIR).
Over the last four decades, Mangalam has acquired worldwide reputation as a single stop destination for frontline Anti-malaria. We also have a diversified product range like Anti-retroviral, Anti-Viral, Anti Inflammatory, Rheumatic Arthritis Agent, Uricosuric, Anti– Convulsant, Anti-Hyperliporoteinemic, Anti – Hypertensive and Anti-Bacterial APIs. Mangalam is amongst the top companies in Asia in all the products it makes; and is also the largest manufacturer of some of its products in the world.
Along with the WHO-GENEVA GMP Certification and EDQM approval for its API manufacturing plant, the company is also in an agreement with the prestigious Clinton Health Access Initiatives (CHAI) under its Fight Malaria Program for supply of anti-malaria APIs worldwide.